Quercetagitrin Inhibits Tau Accumulation and Reverses Neuroinflammation and Cognitive Deficits in P301S-Tau Transgenic Mice
Molecules · 2023
DOI: 10.3390/molecules28093964 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Suyue Zhong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Key Laboratory of Marine Biotechnology and Ecology, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen 518060, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Tauopathies. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shenzhen Science and Technology Innovation Commission, Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions.
Abstract (Originalsprache)
Intracellular tau accumulation is a hallmark pathology of Alzheimer’s disease (AD) and other tauopathies. Tau protein, in the hyperphosphorylated form, is the component of paired helical filaments (PHFs) and neurofibrillary tangles (NFTs) in AD. Blocking tau aggregation and/or phosphorylation is currently a promising strategy for AD treatment. Here, we elucidate that quercetagitrin, a natural compound derived from African marigold (Tagetes erecta), could inhibit tau aggregation and reduce tau phosphorylation at multiple disease-related sites in vitro. Moreover, the in vivo effect of quercetagitrin was assessed in P301S-tau transgenic via oral administration. The compound treatment restored the cognitive deficits and neuron loss in the mice. The formation of NFTs and tau phosphorylations in the hippocampus and cortex of the mice was also prevented by the compound. Moreover, quercetagitrin feeding displayed neuroinflammation protection through the inhibition of NF-κB activation in the mice. Together, our data reveal that quercetagitrin possesses the potential to further develop as a therapeutic medicine for AD and other tauopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shenzhen Key Laboratory of Marine Biotechnology and Ecology, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen 518060, China.
- School of Chemistry and Chemical and Engineering, Guangxi Minzu University, Nanning 530008, China.
- Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions, Shenzhen 518055, China.
ORCID-Profile: Shifeng Xiao
Förderung
- National Natural Science Foundation of China
- Shenzhen Science and Technology Innovation Commission
- Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions
- Shenzhen–Hong Kong Institute of Brain Science–Shenzhen Fundamental Research Institutions
Zitieren
APA
Zhong, S., Ye, J., Deng, Y., Zhang, M., Zou, M., Yao, X., & Xiao, S. (2023). Quercetagitrin Inhibits Tau Accumulation and Reverses Neuroinflammation and Cognitive Deficits in P301S-Tau Transgenic Mice. Molecules. https://doi.org/10.3390/molecules28093964
Vancouver
Zhong S, Ye J, Deng Y, Zhang M, Zou M, Yao X, et al. Quercetagitrin Inhibits Tau Accumulation and Reverses Neuroinflammation and Cognitive Deficits in P301S-Tau Transgenic Mice. Molecules. 2023. doi:10.3390/molecules28093964
BibTeX
@article{Zhong2023,
author = {Zhong, Suyue and Ye, Jinwang and Deng, Yunsong and Zhang, Mohan and Zou, Miaozhan and Yao, Xuanbao and Xiao, Shifeng},
title = {Quercetagitrin Inhibits Tau Accumulation and Reverses Neuroinflammation and Cognitive Deficits in P301S-Tau Transgenic Mice},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28093964}
}
EUVIMED